首页|从肝治心组方通过Nrf2/HO-1通路对缺氧/复氧损伤H9c2心肌细胞铁死亡的影响

从肝治心组方通过Nrf2/HO-1通路对缺氧/复氧损伤H9c2心肌细胞铁死亡的影响

扫码查看
目的:基于核因子E2相关因子2(Nrf2)/血红素氧合酶1(HO-1)信号通路探讨从肝治心组方对大鼠H9c2心肌细胞铁死亡的影响。方法:本研究采用H9c2心肌细胞缺氧/复氧(H/R)方法模拟心肌缺血再灌注损伤(MIRI)细胞模型,细胞分为:空白对照组、模型对照组、15%正常对照血清组、26。6 g/kg从肝治心组方含药血清15%组、NK252 20 μmol/L组、ML385 5μmol/L组、26。6 g/kg从肝治心组方含药血清15%+ML385 5 μmol/L组,通过CCK-8法检测细胞活力;DCFH-DA荧光探针检测细胞内活性氧(ROS)水平;TMRE荧光探针检测细胞线粒体膜电位水平;FerroOrange荧光探针检测细胞内Fe2+水平;RT-qPCR、Werstern blot法检测核因子E2相关因子2(Nrf2)、血红素氧合酶1(Ho1)、膜铁转运辅助蛋白(Heph)、二价金属离子转运体(Dmt1)、酰基辅酶A合成酶长链家族成员4(Acsl4)mRNA和蛋白表达。结果:与正常对照组比较,模型对照组线粒体膜电位水平降低,ROS及Fe2+水平升高,Nrf2、Ho1、Heph mRNA及蛋白表达下调,Dmt1、Acsl4 mRNA及蛋白表达上调(P<0。05或P<0。01);与模型对照组比较,从肝治心组方含药血清组和NK252组线粒体膜电位水平升高,ROS及Fe2+水平降低,Nrf2、Ho1、Heph mRNA及蛋白表达上调,Dmt1、Acsl4 mRNA及蛋白表达下调(P<0。05或P<0。01);与ML385 5 μmol/L组比较,从肝治心组方+ML385 5 μmol/L组线粒体膜电位水平升高,ROS及Fe2+水平降低,Nrf2、Ho1、Heph mRNA及蛋白表达上调,Dmt1、Acsl4 mRNA及蛋白表达下调(P<0。05或P<0。01)。结论:从肝治心组方可能通过调控Nrf2/HO-1信号通路,减轻缺氧/复氧损伤的H9c2心肌细胞铁死亡。
Conggan Zhixin(从肝治心)Decoction Regulates Ferroptosis in H9c2 Cardiomyocytes Exposed to Hypoxia/Reoxygenation Injury via Nrf2/HO-1 Pathway
Objective:To investigate the effects of Conggan Zhixin(从肝治心)Decoction on ferroptosis of H9c2 cardiomyocytes via the nuclear factor E2-related factor 2(Nrf2)/heme oxygenase-1(HO-1)signaling pathway.Methods:H9c2 cardiomyocytes were exposed to hypoxia/reoxygenation(H/R)to establish a cell model of myocardial ischemia-reperfusion injury(MIRI).Cells were classified into normal control,model control,15%blank serum control group,26.6 g/kg Conggan Zhixin Decoction-containing serum(15%),NK252(20 μmol/L),ML385(5 μmol/L),and 26.6 g/kg Conggan Zhixin Decoction-containing serum(15%)+ML385(5 μmol/L)groups.The Cell Counting Kit-8(CCK-8)was used to examine cell viability.DCFH-DA,TMRE,and FerroOrange probes were used to measure the levels of reactive oxygen species(ROS),mitochondrial membrane potential,and intracellular Fe2+.western blotting and Real-time reverse transcription polymerase chain reaction(RT-qPCR)were employed to determine the protein levels and mRNA of Nrf2,HO-1,hephaestin(Heph),divalent metal transporter 1(DMT1),and acyl-CoA synthetase long-chain family member 4(ACSL4).Results:Compared with the normal control group,the model control group showed decreased mitochondrial membrane potential,elevated ROS and Fe2+levels,down-regulated expression of Nrf2,HO-1,and Heph,and up-regulated expression of DMT1 and ACSL4(P<0.05,P<0.01).Compared with the model control group,26.6 g/kg Conggan Zhixin Decoction-containing serum(15%)and NK252(20 μmol/L)groups showed increased mitochondrial membrane potential,lowered ROS and Fe2+levels,up-regulated expression of Nrf2,HO-1,and Heph,and down-regulated expression of DMT 1 and ACSL4(P<0.05,P<0.01).Compared with the ML385(5 μmol/L)group,the 26.6 g/kg Conggan Zhixin Decoction-containing serum(15%)+ML385(5 μmol/L)group showed increased mitochondrial membrane potential,lowered ROS and Fe2+levels,up-regulated expression of Nrf2,HO-1,and Heph,and down-regulated expression of DMT1 and ACSL4(P<0.05,P<0.01).Conclusion:Conggan Zhixin Decoction may attenuate ferroptosis in H9c2 cardiomyocytes exposed to H/R injury by modulating the Nrf2/HO-1 signaling pathway.

Conggan Zhixin(从肝治心)DecoctionFerroptosisMyocardial ischemia-reperfusion injuryHypoxia/reoxygenationNuclear factor E2-related factor 2(Nrf2)/heme oxygenase-1(HO-1)

何飘、朴美虹、谢丽华、曾阳、王瑾茜、汪辛强、张程程、胡国恒、陈亚

展开 >

湖南中医药大学第一附属医院,长沙 410007

湖南中医药大学,长沙 410208

从肝治心组方 铁死亡 心肌缺血再灌注损伤 缺氧/复氧 核因子E2相关因子2/血红素氧合酶1

胡国恒全国名老中医药专家传承工作室建设项目湖南省自然科学基金项目湖南省自然科学基金项目湖南省中医药管理局科研项目湖南省中医药管理局科研项目长沙市科技计划项目长沙市科技计划项目湖南省卫健委科研计划项目湖南中医药大学校级科研基金项目湖南中医药大学研究生创新课题立项项目

国中医药函人教函[2022]75号2021JJ404182020JJ447620211722021179kq2014222kq20142242021030108642019XJJJ0572022CX32

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(1)
  • 22